James Hippel, Chief Financial Officer at BIO-TECHNE Corp (TECH), sold 68,400 shares at $215.36 ($14.7M) on 2019-11-21, disclosed to the SEC on 2019-11-25.
Open-market sale of $14.7M TECH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $215.36 | 11,349 | $2.4M | 16.6% |
| 2 | $215.36 | 11,349 | $2.4M | 16.6% |
| 3 | $215.55 | 22,051 | $4.8M | 32.2% |
| 4 | $215.55 | 22,051 | $4.8M | 32.2% |
| 5 | $216.16 | 1,600 | $346K | 2.3% |
| Total | $215.50 avg | 68,400 |
| $14.7M |
| 100% |
| Filing → |
| TECH | SELL | 2021-09-07 | $10.1M | — | Filing → |
| TECH | SELL | 2021-08-10 | $4.8M | — | Filing → |
| TECH | SELL | 2021-07-14 | $8.0M | — | Filing → |